+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Procyanidin C1

BP1149
37064-30-5
98%
Phytounique
Crataegi fructus
Procyanidin C1 has anti-inflammatory effects, can inhibit IKKb activity in vitro and reduce the LPS-induced production of ROS, thus, it exerts the anti-inflammatory effects by inhibiting ERK1/2 and IKKb activity. Procyanidin C1 could be useful as a lead compound to develop inhibitors of cancer metastasis and other diseases related to epithelial-to-mesenchymal transition (EMT). Procyanidin C1 may represent a novel and potentially therapeutically relevant compound for the treatment of cardiovascular diseases, it -induced vasorelaxation is associated with the activation of the calcium-dependent NO/cGMP pathway, involving potassium channel activation. Procyanidin C1 is a proanthocyanidin consisting of three ()-epicatechin units joined by two successive (4beta8)-linkages. It has a role as an antioxidant, a metabolite, an EC 1.17.3.2 (xanthine oxidase) inhibitor, a lipoxygenase inhibitor, an anti-inflammatory agent and an EC 3.2.1.20 (alpha-glucosidase) inhibitor. It is a polyphenol, a proanthocyanidin and a hydroxyflavan. It is functionally related to a (-)-epicatechin.
Catalog No Package Original Price Price Inventory Quantity Operating
BP1149-10mg 10mg
BP1149-20mg 20mg
BP1149-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Product drug property prediction parameters

  • 331.1400

  • 2.4036

  • 2.4031

  • .0306

  • .9479

  • .6134

  • Low

  • 89.0918

  • 5.3547

  • No

  • No

  • No

  • No

  • Yes

  • No

  • 0.0

  • Yes

  • No

  • Yes

  • No